Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sirolimus × Breast × Clear all

Phase

Status

Completed 8 Active not recruiting 3 Terminated 2 Not yet recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Gastrointestinal 2 Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Capecitabine 82 Cyclophosphamide 79 Trastuzumab 71 Docetaxel 70 Paclitaxel 60 Tamoxifen 49 Fulvestrant 47 Epirubicin 47 pyrotinib 44 Letrozole 42 Vinorelbine 40 Carboplatin 40 Doxorubicin 39 Radiotherapy 33 exemestane 28 Anastrozole 28 Neoadjuvant Therapy 25 palbociclib 24 Drug Therapy 23 Bevacizumab 23 Fluorouracil 21 Cisplatin 20 pertuzumab 19 eribulin 19 Gemcitabine 19 130-nm albumin-bound paclitaxel 18 Goserelin 17 Exercise 17 Chemotherapy, Adjuvant 17 Albumin-Bound Paclitaxel 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03805399 2022-08-10

FUTURE

Fudan University

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡